volume 14 issue 6 pages 889-919

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

Mohammed Eslam 1
Shiv K. Sarin 2
Vincent Wai-Sun Wong 3
Jian-Gao Fan 4
Takumi Kawaguchi 5
Sang Hoon Ahn 6
Ming-Hua Zheng 7, 8
Gamal Shiha 9, 10
Yusuf Yilmaz 11, 12
Rino Gani 13
Shahinul Alam 14
Yock-Young Dan 15
Jia-Horng Kao 16, 17, 18, 19
Saeed Hamid 20
Ian Homer Cua 21
Wah-Kheong Chan 22
Diana Payawal 23
Soek-Siam Tan 24
Tawesak Tanwandee 25
Leon A. Adams 26
Manoj Kumar 2
Masao OMATA 27, 28
Jacob George 1
10
 
Egyptian Liver Research Institute and Hospital (ELRIAH), El Mansoura, Egypt
21
 
Institute of Digestive and Liver Diseases, St. Luke’s Medical Center, Global City, Philippines
23
 
Department of Medicine, Cardinal Santos Medical Center, Mandaluyong, Philippines
24
 
Department of Hepatology, Selayang Hospital, Batu Caves, Malaysia
27
 
Department of Gastroenterology, Yamanashi Central Hospital, Yamanashi, Japan
Publication typeJournal Article
Publication date2020-10-01
scimago Q1
wos Q1
SJR1.986
CiteScore11.2
Impact factor6.1
ISSN19360533, 19360541
Hepatology
Abstract
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The objective of this work was to present the clinical practice guidelines of the Asian Pacific Association for the Study of the Liver (APASL) on MAFLD. The guidelines cover various aspects of MAFLD including its epidemiology, diagnosis, screening, assessment, and treatment. The document is intended for practical use and for setting the stage for advancing clinical practice, knowledge, and research of MAFLD in adults, with specific reference to special groups as necessary. The guidelines also seek to improve patient care and awareness of the disease and assist stakeholders in the decision-making process by providing evidence-based data. The guidelines take into consideration the burden of clinical management for the healthcare sector.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
Hepatology International
34 publications, 5.42%
Nutrients
14 publications, 2.23%
Frontiers in Nutrition
12 publications, 1.91%
Journal of Hepatology
12 publications, 1.91%
Therapeutic Advances in Endocrinology and Metabolism
12 publications, 1.91%
Scientific Reports
12 publications, 1.91%
Frontiers in Endocrinology
11 publications, 1.75%
Liver International
11 publications, 1.75%
International Journal of Molecular Sciences
10 publications, 1.59%
Journal of Clinical Medicine
10 publications, 1.59%
Annals of Hepatology
10 publications, 1.59%
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
9 publications, 1.44%
Journal of Clinical and Translational Hepatology
9 publications, 1.44%
World Journal of Gastroenterology
8 publications, 1.28%
HepatoBiliary Surgery and Nutrition
8 publications, 1.28%
Hepatology Communications
7 publications, 1.12%
World Journal of Hepatology
7 publications, 1.12%
Clinical Gastroenterology and Hepatology
6 publications, 0.96%
BMC Gastroenterology
6 publications, 0.96%
Lipids in Health and Disease
6 publications, 0.96%
Diabetes, Obesity and Metabolism
6 publications, 0.96%
Diabetes Care
6 publications, 0.96%
The Lancet Gastroenterology and Hepatology
5 publications, 0.8%
Hepatology
5 publications, 0.8%
Biomedicines
5 publications, 0.8%
Nature Reviews Gastroenterology and Hepatology
5 publications, 0.8%
Diabetology and Metabolic Syndrome
5 publications, 0.8%
Clinical and molecular hepatology
5 publications, 0.8%
BMJ Open
5 publications, 0.8%
5
10
15
20
25
30
35

Publishers

20
40
60
80
100
120
140
Springer Nature
136 publications, 21.69%
Elsevier
104 publications, 16.59%
MDPI
63 publications, 10.05%
Wiley
61 publications, 9.73%
Frontiers Media S.A.
39 publications, 6.22%
Ovid Technologies (Wolters Kluwer Health)
30 publications, 4.78%
Taylor & Francis
26 publications, 4.15%
SAGE
19 publications, 3.03%
Baishideng Publishing Group
16 publications, 2.55%
BMJ
10 publications, 1.59%
Xia & He Publishing
9 publications, 1.44%
AME Publishing Company
9 publications, 1.44%
OAE Publishing Inc.
7 publications, 1.12%
American Diabetes Association
6 publications, 0.96%
Hindawi Limited
5 publications, 0.8%
The Korean Association for the Study of the Liver
5 publications, 0.8%
Georg Thieme Verlag KG
5 publications, 0.8%
The Endocrine Society
4 publications, 0.64%
Hans Publishers
4 publications, 0.64%
Public Library of Science (PLoS)
4 publications, 0.64%
Mary Ann Liebert
3 publications, 0.48%
Ediciones Medicina y Cultura
3 publications, 0.48%
S. Karger AG
3 publications, 0.48%
Medknow
3 publications, 0.48%
American Association of Clinical Endocrinology
2 publications, 0.32%
Cambridge University Press
2 publications, 0.32%
American Chemical Society (ACS)
2 publications, 0.32%
Editorial Office of Gut and Liver
2 publications, 0.32%
Royal Society of Chemistry (RSC)
2 publications, 0.32%
20
40
60
80
100
120
140
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
629
Share
Cite this
GOST |
Cite this
GOST Copy
Eslam M. et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease // Hepatology International. 2020. Vol. 14. No. 6. pp. 889-919.
GOST all authors (up to 50) Copy
Eslam M., Sarin S. K., Wong V. W., Fan J., Kawaguchi T., Ahn S. H., Zheng M., Shiha G., Yilmaz Y., Gani R., Alam S., Dan Y., Kao J., Hamid S., Cua I. H., Chan W., Payawal D., Tan S., Tanwandee T., Adams L. A., Kumar M., OMATA M., George J. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease // Hepatology International. 2020. Vol. 14. No. 6. pp. 889-919.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s12072-020-10094-2
UR - https://doi.org/10.1007/s12072-020-10094-2
TI - The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
T2 - Hepatology International
AU - Eslam, Mohammed
AU - Sarin, Shiv K.
AU - Wong, Vincent Wai-Sun
AU - Fan, Jian-Gao
AU - Kawaguchi, Takumi
AU - Ahn, Sang Hoon
AU - Zheng, Ming-Hua
AU - Shiha, Gamal
AU - Yilmaz, Yusuf
AU - Gani, Rino
AU - Alam, Shahinul
AU - Dan, Yock-Young
AU - Kao, Jia-Horng
AU - Hamid, Saeed
AU - Cua, Ian Homer
AU - Chan, Wah-Kheong
AU - Payawal, Diana
AU - Tan, Soek-Siam
AU - Tanwandee, Tawesak
AU - Adams, Leon A.
AU - Kumar, Manoj
AU - OMATA, Masao
AU - George, Jacob
PY - 2020
DA - 2020/10/01
PB - Springer Nature
SP - 889-919
IS - 6
VL - 14
PMID - 33006093
SN - 1936-0533
SN - 1936-0541
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Eslam,
author = {Mohammed Eslam and Shiv K. Sarin and Vincent Wai-Sun Wong and Jian-Gao Fan and Takumi Kawaguchi and Sang Hoon Ahn and Ming-Hua Zheng and Gamal Shiha and Yusuf Yilmaz and Rino Gani and Shahinul Alam and Yock-Young Dan and Jia-Horng Kao and Saeed Hamid and Ian Homer Cua and Wah-Kheong Chan and Diana Payawal and Soek-Siam Tan and Tawesak Tanwandee and Leon A. Adams and Manoj Kumar and Masao OMATA and Jacob George},
title = {The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease},
journal = {Hepatology International},
year = {2020},
volume = {14},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1007/s12072-020-10094-2},
number = {6},
pages = {889--919},
doi = {10.1007/s12072-020-10094-2}
}
MLA
Cite this
MLA Copy
Eslam, Mohammed, et al. “The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.” Hepatology International, vol. 14, no. 6, Oct. 2020, pp. 889-919. https://doi.org/10.1007/s12072-020-10094-2.